European Sovereignty Monitor
Sign up free

Industry, investment and R&D

Owkin licenses K Pro AI scientist and patient data to Servier for oncology research

Owkin, the Paris based AI biotech, licensed its K Pro AI Scientist platform and multimodal patient data from its MOSAIC network to French drugmaker Servier, extending an existing oncology research partnership. No financial terms were disclosed.

Verified AI-drafted Owkin press release, 11 September 2026

What the source does not establish. Does not disclose deal value, exclusivity terms, or any change in data ownership, infrastructure control or supply chain dependency between the two firms.

Index score. No movement: no answer to who owns, who operates, whose law governs or who made the parts changes. Weight 0. licensing deal between two French firms; no change in own/operate/law/parts disclosed. European Sovereignty Index

How this item was made. Drafted by an AI system (Claude (Anthropic)) from the source cited above and published under the editor’s responsibility without a person reading it first. How the record is made

What the tags mean: VerifiedReportedAI-draftedAI-drafted, editor-readHuman-writtenWhat the tags mean

Previously in Industry, investment and R&D

ReportedAI-drafted EU's EIC backs Paris satellite-to-phone start-up Univity with up to EUR 12.5 million VerifiedAI-drafted Wallenberg Investments takes minority stake in Swedish simulation firm Algoryx ReportedAI-drafted Dutch startup Elysian Aircraft raises over EUR 12 million for dual-use aircraft tech

All Industry, investment and R&D news →